SV Health Investors and Third Rock Ventures have given PanOptica the money to take its lead drug into a phase 1/2 wet age-related macular degeneration (AMD) trial. PanOptica plans to start trialling ...
Pro Prices of AMD's popular Ryzen 5 series doubled since February 1st to $400 — nobody knows why, but here's what may have happened Pro There are 37 AMD Ryzen AI MAX+ 395 mini PCs in the world right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results